Rani Therapeutics Holdings Inc (RANI) — Financial Flexibility Index

Latest as of September 2025: -0.23x

Rani Therapeutics Holdings Inc (RANI) has a Financial Flexibility Index of -0.23x as of September 2025. Free cash flow of $-5.06 Million (operating CF $-5.06 Million minus capex $0.00) represents 0% of total liabilities ($22.11 Million). Also explore RANI shareholders equity momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.23x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-5.06 Million
Operating CF − Capex

Total Liabilities

$22.11 Million
USD

Capital Expenditures

$0.00
USD

Rani Therapeutics Holdings Inc Financial Flexibility Index (2019–2024)

Historical Financial Flexibility Index trend for Rani Therapeutics Holdings Inc across 6 annual periods. Check RANI PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Rani Therapeutics Holdings Inc (2019–2024)

Year-by-year free cash flow to debt coverage for Rani Therapeutics Holdings Inc. For the full company profile including market capitalisation, see Rani Therapeutics Holdings Inc market capitalisation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -1.06x $-35.23 Million $-35.50 Million $33.14 Million ▲ +31.0%
2023 -1.54x $-50.01 Million $-51.24 Million $32.47 Million ▼ -16.7%
2022 -1.32x $-44.90 Million $-46.52 Million $34.02 Million ▲ +89.0%
2021 -12.02x $-31.74 Million $-32.24 Million $2.64 Million ▼ -16741.2%
2020 -0.07x $-13.76 Million $-14.96 Million $192.75 Million ▲ +65.4%
2019 -0.21x $-24.69 Million $-26.27 Million $119.66 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities